局所避妊薬の世界市場

Technavioが発行した調査報告書(IRTNTR12959)
◆英語タイトル:Global Topical Contraceptive Market 2017-2021
◆商品コード:IRTNTR12959
◆発行会社(リサーチ会社):Technavio
◆発行日:2017年5月24日
◆ページ数:70
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:グローバル
◆産業分野:医療・製薬
◆販売価格オプション(消費税別)
Single User(1名利用)USD3,500 ⇒換算¥378,000見積依頼/購入/質問フォーム
Five User(~5名利用)USD4,000 ⇒換算¥432,000見積依頼/購入/質問フォーム
Enterprise License(全社内共有可)USD5,000 ⇒換算¥540,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はTechnavio社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。Technavio社の概要及び新刊レポートはこちらでご確認いただけます。

当調査レポートでは、局所避妊薬の世界市場について調査・分析し、エグゼクティブサマリー、市場概観、市場概観、業界の構造分析、局所避妊薬の世界市場規模及び予測、地域別分析/市場規模、市場の成長要因、市場の課題、市場動向、競争状況などの情報をお届けいたします。

・エグゼクティブサマリー
・局所避妊薬の世界市場:市場概観
・局所避妊薬の世界市場:業界の構造分析
・局所避妊薬の世界市場:市場規模及び予測
・局所避妊薬の世界市場:地域別分析
・局所避妊薬の世界市場:アジア市場規模
・局所避妊薬の世界市場:アメリカ市場規模
・局所避妊薬の世界市場:ヨーロッパ市場規模
・局所避妊薬の世界市場:成長要因
・局所避妊薬の世界市場:課題
・局所避妊薬の世界市場:市場動向
・局所避妊薬の世界市場:競争状況
...

※上記の和訳は最新内容ではない場合があります。
【レポートの概要】

About Topical Contraceptive
Topical contraceptives are contraceptive patches that release hormones, estrogen, and progestin to prevent pregnancies. They work in a similar manner as oral contraceptives. Various temporary and permanent contraceptive methods and devices for women are available in the market. Permanent methods such as sterilization are considered the most effective as they eliminate the chances of pregnancy.

Technavio’s analysts forecast the global topical contraceptive market to grow at a CAGR of 2% during the period 2017-2021.

[Covered in this report]
The report covers the present scenario and the growth prospects of the global topical contraceptive market for 2017-2021. To calculate the market size, the report considers the revenue generated from the sales of topical contraceptives.

The market is divided into the following segments based on geography:
• Americas
• APAC
• EMEA

Technavio’s report, Global Topical Contraceptive Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

[Key vendors]
• ALLERGAN
• Mylan
• Merck Millipore
• Pfizer
• Teva Pharmaceuticals

[Other prominent vendors]
• Afaxys
• Agile Therapeutics
• Ansell
• Bayer Pharma
• Caya
• Ferring Pharmaceuticals
• Female Health
• Fuji Latex
• HLL Lifecare
• Janssen Pharmaceutical
• Lipocine
• Lupin Pharmaceuticals
• Mayer Laboratories
• Okamoto Industries
• Reckitt Benckiser
• Syzygy Healthcare

[Market driver]
• Proliferation of strategic initiatives
• For a full, detailed list, view our report

[Market challenge]
• High preference for other types of contraceptives
• For a full, detailed list, view our report

[Market trend]
• Increasing demand for other contraceptive methods
• For a full, detailed list, view our report

[Key questions answered in this report]
• What will the market size be in 2021 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?

*** You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.

【レポートの目次】

Table of Contents
PART 01: Executive summary

PART 02: Scope of the report

PART 03: Research Methodology

PART 04: Market landscape
• Market overview
• Five forces analysis

PART 05: Geographical segmentation
• Overview
• Americas
• EMEA
• APAC

PART 06: Distribution channel segmentation
• Overview
• Retail outlets
• Online stores

PART 07: Decision framework

PART 08: Drivers and challenges
• Market drivers
• Market challenges

PART 09: Market trends
• Increasing awareness through social media marketing
• Increasing demand for other contraceptive methods
• Increasing investments in women’s health
• Rising first-time pregnancy age

PART 10: Vendor landscape
• Competitive scenario
• Investment opportunity
• ALLERGAN
• Mylan
• Merck Millipore
• Pfizer
• Teva Pharmaceuticals
• Other prominent vendors

PART 11: Appendix
• List of abbreviations

[List of Exhibits] Exhibit 01: Contraceptive types: Advantages and disadvantages
Exhibit 02: Global topical contraceptive market 2016-2021 ($ millions)
Exhibit 03: Effectiveness of family planning methods
Exhibit 04: Top-ranked women health issues 2015
Exhibit 05: Five forces analysis
Exhibit 06: Global topical contraceptives market: Geographical segmentation 2016-2021 (market share)
Exhibit 07: Topical contraceptive market in Americas 2016-2021 ($ millions)
Exhibit 08: Leading countries in Americas: Overview
Exhibit 09: Topical contraceptive market in EMEA 2016-2021 ($ millions)
Exhibit 10: Leading countries in EMEA: Overview
Exhibit 11: Topical contraceptive market in APAC 2016-2021 ($ millions)
Exhibit 12: Leading countries in APAC: Overview
Exhibit 13: Global topical contraceptives market: Distribution channels 2016-2021 (market share)
Exhibit 14: Global topical contraceptive market: Retail outlets 2016-2021 ($ millions)
Exhibit 15: Global topical contraceptive market: Online stores 2016-2021 ($ millions)
Exhibit 16: Penetration of Internet 2016 (%)
Exhibit 17: Unplanned pregnancies by region 2015 (millions)
Exhibit 18: Companies focusing on various women’s health issues
Exhibit 19: Increase in pregnancy rate among women age 30 and older (per 1,000) in US
Exhibit 20: Global topical contraceptive market: Competitive parameters
Exhibit 21: Strategic success factor of companies
Exhibit 22: Investment opportunity mapping
Exhibit 23: Key takeaways: ALLERGAN
Exhibit 24: Key takeaways: Mylan
Exhibit 25: Key takeaways: Merck Millipore
Exhibit 26: Key takeaways: Pfizer
Exhibit 27: Key takeaways: Teva Pharmaceuticals



【掲載企業】

ALLERGAN, Mylan, Merck Millipore, Pfizer, Teva Pharmaceuticals, Afaxys, Agile Therapeutics, Ansell, Bayer Pharma, Caya, Ferring Pharmaceuticals, Female Health, Fuji Latex, HLL Lifecare, Janssen Pharmaceutical, Lipocine, Lupin Pharmaceuticals, Mayer Laboratories, Okamoto Industries, Reckitt Benckiser and Syzygy Healthcare.

【レポートのキーワード】

局所避妊、局所避妊薬

【リサーチ方法】

一次資料による調査(業界専門家、ベンダー、代理店、顧客等を対象にしたデプスインタビュー調査など)及び二次資料による調査(Technavio独自のプラットフォーム、産業書籍、企業報告書、ニュース記事、アナリストレポート、貿易協会、政府機関発行データなど)

【免責事項】
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 局所避妊薬の世界市場(Global Topical Contraceptive Market 2017-2021)]についてメールでお問い合わせはこちらでお願いします。


◆H&Iグローバルリサーチのお客様(例)◆